Literature DB >> 18379806

Long-term disease-free survival after hormonal therapy of a patient with recurrent low grade endometrial stromal sarcoma: a case report.

Ozkan Alkasi1, Ivo Meinhold-Heerlein, Rania Zaki, Peter Fasching, Nicolai Maass, Walter Jonat, Matthias W Beckmann.   

Abstract

BACKGROUND: Approximately 50% of patients with low-grade endometrial stromal sarcoma (ESS) develop recurrent disease including mainly metastases of pelvis and lung. A solitary pulmonary metastasis of this disease is a rare phenomenon. CASE: After initial surgical treatment in 1990, a 28-year-old female developed solitary metastases of the lung in 1998 and 1999, which were surgically removed both times. The patient was then treated with goserelin for 2 years followed by anastrozole to date. She has since been disease-free.
CONCLUSIONS: This case report emphasizes the importance of long-term follow-up and initial surgical treatment of low-grade ESS and suggests systemic hormonal therapy in case of recurrence.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18379806     DOI: 10.1007/s00404-008-0631-6

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  8 in total

1.  Long-term medroxyprogesterone acetate therapy for low-grade endometrial stromal sarcoma.

Authors:  Mika Mizuno; Yasushi Yatabe; Akihiro Nawa; Toru Nakanishi
Journal:  Int J Clin Oncol       Date:  2011-08-10       Impact factor: 3.402

2.  Long-term treatment of residual or recurrent low-grade endometrial stromal sarcoma with aromatase inhibitors: A report of two cases and a review of the literature.

Authors:  Hyewon Ryu; Yoon-Seok Choi; Ik-Chan Song; Hwan-Jung Yun; Deog-Yeon Jo; Samyong Kim; Hyo Jin Lee
Journal:  Oncol Lett       Date:  2015-09-03       Impact factor: 2.967

Review 3.  Hormonal treatment in recurrent and metastatic gynaecological cancers: a review of the current literature.

Authors:  Dirkje W Sommeijer; Katrin M Sjoquist; Michael Friedlander
Journal:  Curr Oncol Rep       Date:  2013-12       Impact factor: 5.075

4.  Endometrial stromal sarcoma with selective polyvinyl alcohol embolization of a pulmonary metastasis after recurrent hemoptysis and expansive growth.

Authors:  Maximilian de Bucourt; Florian Streitparth; Thula Walter; Ulf Teichgräber
Journal:  Rare Tumors       Date:  2010-06-30

5.  Endometrial stromal sarcoma: A review of the literature.

Authors:  Geetha Puliyath; M Krishnan Nair
Journal:  Indian J Med Paediatr Oncol       Date:  2012-01

Review 6.  Hormonal therapy in uterine sarcomas.

Authors:  Yuqin Zang; Mengting Dong; Kai Zhang; Chao Gao; Fei Guo; Yingmei Wang; Fengxia Xue
Journal:  Cancer Med       Date:  2019-03-21       Impact factor: 4.452

7.  Complete remission of advanced low-grade endometrial stromal sarcoma after aromatase inhibitor therapy: a case report.

Authors:  Omar F Altal; Ahmed H Al Sharie; Omar M Halalsheh; Nour Tashtush; Sarat Shaban; Mahmoud Alfaqih; Abdelwahab Aleshawi
Journal:  J Med Case Rep       Date:  2021-05-05

Review 8.  New Insights into Hormonal Therapies in Uterine Sarcomas.

Authors:  Elena Maccaroni; Valentina Lunerti; Veronica Agostinelli; Riccardo Giampieri; Laura Zepponi; Alessandra Pagliacci; Rossana Berardi
Journal:  Cancers (Basel)       Date:  2022-02-12       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.